INCLUSIVE Trademark

Trademark Overview

On Friday, July 25, 2003, a trademark application was filed for INCLUSIVE with the United States Patent and Trademark Office. The USPTO has given the INCLUSIVE trademark a serial number of 78278816. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, October 26, 2006. This trademark is owned by Sanofi-Synthelabo. The INCLUSIVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

clinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals

General Information

Serial Number78278816
Word MarkINCLUSIVE
Filing DateFriday, July 25, 2003
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, October 26, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesclinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 6, 2003
Primary Code042
First Use Anywhere DateSaturday, November 8, 2003
First Use In Commerce DateSaturday, November 8, 2003

Trademark Owner History

Party NameSANOFI-AVENTIS
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
Address75013 PARIS
FR
Party NameSanofi-Synthelabo
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75013
FR

Trademark Events

Event DateEvent Description
Friday, October 27, 2006ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, October 26, 2006ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, October 26, 2006EXPARTE APPEAL TERMINATED
Thursday, July 27, 2006EX PARTE APPEAL-REFUSAL AFFIRMED
Thursday, March 30, 2006EXAMINERS STATEMENT MAILED
Wednesday, March 29, 2006EXAMINERS STATEMENT - COMPLETED
Thursday, February 2, 2006JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 1, 2006FAX RECEIVED
Wednesday, February 1, 2006FAX RECEIVED
Thursday, January 26, 2006EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Tuesday, October 11, 2005ACTION DENYING REQ FOR RECON MAILED
Tuesday, October 11, 2005ACTION CONTINUING FINAL - COMPLETED
Thursday, October 6, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, September 26, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 28, 2005EX PARTE APPEAL-INSTITUTED
Wednesday, September 28, 2005JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, September 27, 2005EXPARTE APPEAL RECEIVED AT TTAB
Monday, September 26, 2005PAPER RECEIVED
Tuesday, March 22, 2005FINAL REFUSAL MAILED
Monday, March 21, 2005FINAL REFUSAL WRITTEN
Tuesday, March 15, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, February 24, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 24, 2005PAPER RECEIVED
Monday, August 30, 2004NON-FINAL ACTION MAILED
Wednesday, August 25, 2004AMENDMENT FROM APPLICANT ENTERED
Friday, August 6, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 25, 2004AMENDMENT TO USE PROCESSING COMPLETE
Friday, August 6, 2004USE AMENDMENT FILED
Friday, August 6, 2004PAPER RECEIVED
Thursday, February 5, 2004NON-FINAL ACTION MAILED
Wednesday, February 4, 2004ASSIGNED TO EXAMINER

Related Keywords

inclusive clinical pharmaceuticals anti hypertensive research conducting trials namely medical field